Skip to content

A study to examine the effects of oral NTX-1955 on the brain in healthy adults.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521829-32-00
Acronym
NTX-1955-101
Enrollment
18
Registered
2025-06-24
Start date
2025-06-24
Completion date
Unknown
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder (GAD)

Interventions

None listed

Sponsors

Newleos Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026